UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,000 | -8.3% | 1,282 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -45.5% | 1,282 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +10.0% | 1,282 | 0.0% | 0.00% | – |
| Q2 2021 | $20,000 | -20.0% | 1,282 | 0.0% | 0.00% | – |
| Q1 2021 | $25,000 | +8.7% | 1,282 | 0.0% | 0.00% | – |
| Q4 2020 | $23,000 | -8.0% | 1,282 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -24.2% | 1,282 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +43.5% | 1,282 | 0.0% | 0.00% | – |
| Q1 2020 | $23,000 | -46.5% | 1,282 | 0.0% | 0.00% | – |
| Q4 2019 | $43,000 | -25.9% | 1,282 | -47.0% | 0.00% | – |
| Q3 2019 | $58,000 | -33.3% | 2,421 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $87,000 | -2.2% | 2,421 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $89,000 | +81.6% | 2,421 | +112.6% | 0.00% | – |
| Q4 2018 | $49,000 | -9.3% | 1,139 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | -5.3% | 1,139 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $57,000 | – | 1,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |